Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.29
Delayed Data
As of Jul 27
 +0.0669 / +3.01%
Today’s Change
1.63
Today|||52-Week Range
15.45
+13.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues1.0M1.2M1.6M1.7M
 
 
 
 
 
Cost of Goods Sold212.0K228.0K550.0K571.0K
 
 
 
 
 
Depreciation And Amortization41.0K41.0K41.0K40.0K
 
 
 
 
 
 
Operating ExpensesGross Income755.0K931.0K1.0M1.1M
 
 
 
 
 
General Expenses5.6M6.3M7.2M5.6M
 
 
 
 
 
Research And Development1.2M1.9M1.2M842.0K
 
 
 
 
 
Total Operating Expenses5.9M6.5M7.8M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-5.3M-6.1M-4.5M
 
 
 
 
 
Extraordinary Credit0.00139.0K2.0M0.00
 
 
 
Extraordinary Charge0.00--0.00-476.0K
 
 
Other Expenses-22.0K-31.0K-32.0K-68.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.9M-5.2M-4.2M-5.1M
 
 
 
 
 
Income Taxes-6.0K-2.0K-2.0K0.00
 
 
 
 
Net Income-4.9M-5.2M-4.2M-5.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7M3.0M3.3M4.1M
 
 
 
 
 
Shares To Calculate EPS Diluted2.7M3.0M3.3M4.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.75-$1.75-$1.26-$1.24
 
 
 
 
 
EPS Diluted-$1.75-$1.75-$1.26-$1.24